Skip to content

Benitec Biopharma Inc.

BNTC· NasdaqCore metricsCIK 1808898

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -4.10%
Market cap
$329.41M
36.12M shares
Filings
336
$0.00
Q3 2026−100.0% FY24 yoy
-$12.93M
Q1 2027N/M FY26 yoy
-$14.48M
Q1 2027N/M FY26 yoy
-$16.62M
FY 2026derivedN/M FY26 yoy
-$0.26
Q1 2027N/M FY26 yoy
$176.37M
Q1 2027+84.1% FY26 yoy
$329.41M
—
—
1.9×
-5.05%
—

FY2026 figures · derived

Price

$9.1231.22%$4.14past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2024
$12.20M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
PeriodEndedValueKindSource trail
FY 20242024-06-30$0reported
FY 20232023-06-30$75,000reported
FY 20222022-06-30$73,000reported
FY 20212021-06-30$59,000reported
FY 20202020-06-30$102,000reported
FY 20192019-06-30$12,199,000reported

Segments

Products
Revenue by Products, FY2020 to FY2024FY2020Royalty revenue · FY2020 · $93.00KService revenue · FY2020 · $4.00KFY2021Licensing revenue · FY2021 · $59.00KFY2022Licensing revenue · FY2022 · $73.00KFY2023Licensing revenue · FY2023 · $75.00KFY2024
LineFY2024ShareChange
Licensing revenue$0.00—−100.0%
Royalty revenue———
Service revenue———
Total$0.00

From the 10-K filed Sep 26, 2024BNTC

Pharmaceutical preparations

Benitec Biopharma Inc. is the 214th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR